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Abstract: A new ergosterol analog, talarosterone (1) and a new bis-anthraquinone derivative (3)
were isolated, together with ten known compounds including palmitic acid, ergosta-4,6,8(14),22-
tetraen-3-one, ergosterol-5,8-endoperoxide, cyathisterone (2), emodin (4a), questinol (4b), citreorosein
(4c), fallacinol (4d), rheoemodin (4e) and secalonic acid A (5), from the ethyl acetate extract of the
culture of the marine sponge-associated fungus Talaromyces stipitatus KUFA 0207. The structures
of the new compounds were established based on extensive 1D and 2D spectral analysis, and in
the case of talarosterone (1), the absolute configurations of its stereogenic carbons were determined
by X-ray crystallographic analysis. The structure and stereochemistry of cyathisterone (2) was also
confirmed by X-ray analysis. The anthraquinones 4a–e and secalonic acid A (5) were tested for their
anti-obesity activity using the zebrafish Nile red assay. Only citreorosein (4c) and questinol (4b)
exhibited significant anti-obesity activity, while emodin (4a) and secalonic acid A (5) caused toxicity
(death) for all exposed zebrafish larvae after 24 h.
Keywords: Talaromyces stipitatus; Trichocomaceae; anthraquinones; bis-anthraquinone; ergosterol
derivatives; secalonic acid A; anti-obesity; zebrafish Nile red assay
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1. Introduction
The genus Talaromyces (Trichocomaceae), a sexual state of Penicillium, is important because
of its ubiquity. They have been isolated from soil, plants, sponges and foods [1]. The fungi of
this genus produce a wide variety of secondary metabolites including alkaloids, peptides, lactones,
polyketides, and miscellaneous structural type of compounds [2]. Recently, we have reported the
isolation of wortmin, meso-1,4-bis(4-methoxybenzyl)-2,3-butanediol and a new isocoumarin derivative
tratenopyrone from the ethyl acetate extract of the culture of Talaromyces tratensis KUFA 0091, isolated
from the marine sponge Mycale sp., collected from the Gulf of Thailand [3]. During our ongoing
research on secondary metabolites from marine-derived fungi with potential anti-obesity activity, we
have investigated the secondary metabolites of a Thai collection of T. stipitatus KUFA 0207, isolated from
the marine sponge Stylissa flabelliformis, collected from the coral reef at Samaesarn Island in the Gulf
of Thailand. The ethyl acetate extract of the culture of this fungus furnished, in addition to two new
compounds including a new analog of ergosterol: talarosterone (1) and a new bis-anthraquinone
derivative (3), palmitic acid and the previously reported ergosta-4,6,8(14),22-tetraen-3-one [4],
ergosterol 5,8-endoperoxide [5], cyathisterone (2) [6], emodin (4a) [7], questinol (4b) [8], citreorosein
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4a: R1 = R2 = R4 = OH; R3 = Me
4b: R1 = OMe; R2 = R4 = OH; R3 = CH2OH
4c: R1 = R2 = R4 = OH; R3 = CH2OH
4d: R1 = R4 = OH; R2 = OMe; R4 = CH2OH


























































Figure 1. Secondary etabolites fro Talaromyces stipitatus KUFA 0207.
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Obesity is increasing at an alarming rate and only a few medications are currently on the
market [13]. Recent researches demonstrated that many natural products, including secondary
metabolites from plants, cyanobacteria, fungi and phytoplankton, possess anti-obesity activities [14,15].
Although many phenolic compound-containing plant extracts and several of their phenolic constituents
such as flavonoids have been demonstrated to have potential as anti-obesity agents with different
modes of action [15], only a few anthraquinones have been investigated for their anti-obesity potential.
Huang et al. [16] have patented (US 8247001 B2) the anti-obesity product and the method of preparation
of the alcohol extract of Cassia obtusifolia seeds, which contains the anthraquinones aurantio-obtusin,
obtusifolin and their glycosides, for use in the treatment of obesity and related metabolic and liver
diseases. Tzeng et al. [17], in their investigation of the anti-obesity and antihyperlipidaemic effects of
emodin, have found that this anthraquinone caused dose-related reductions in the hepatic triglyceride
and cholesterol contents and lowered hepatic lipid droplets accumulation in high-fat diet-fed rats.
In order to investigate the potential of anthraquinone-producing marine fungi as a source of anti-obesity
compounds, anthraquinones 4a–e and secalonic acid A (5) were evaluated for their anti-obesity
activity using the zebrafish Nile red assay. Zebrafish is gaining popularity as a screening system for
bioactive compounds with the advantages of a small whole animal model, and higher physiological
relevance over cellular in vitro models [18]. The zebrafish larvae Nile red assay is suitable to detect
anti-obesogenic activities since zebrafish larvae were demonstrated to respond to known lipid regulator
drugs similarly as humans [19].
2. Results and Discussion
The molecular formula C28H40O3 of compound 1, a white crystal (mp, 145–148 ◦C), was
established based on the (+)-HRESIMS m/z 425.3056 [M + H]+ (calculated 425.3056), indicating
nine degrees of unsaturation. The IR spectrum showed absorption bands for conjugated ketone
carbonyl (1689, 1670 cm−1) and olefin (1593 cm−1) groups. The 1H and 13C NMR spectra (Table 1,
Supplementary Information, Figures S1 and S2) of 1 showed similar characteristics of ergosterol
derivatives. The 13C NMR spectrum of 1 showed the presence of twenty-eight carbon signals which
can be classified, by DEPTs and HSQC spectra (Supplementary Information, Figure S4), as two
conjugated ketone carbonyl (δC 199.5 and 195.9), one quaternary sp2 (δC 155.0), three methine sp2
(δC 135.0, 132.5, 129.2), one oxyquaternary sp3 (δC 66.2), two quaternary sp3 (δC 44.3, 36.8), seven
methine sp3 (δC 56.1, 56.0, 51.8, 43.9, 42.8, 40.0, 33.0), six methylene sp3 (δC 39.0, 37.1, 33.8, 27.7, 20.7,
18.7), two tertiary methyl (δC 21.8, 12.4) and four secondary methyl (δC 21.0, 20.0, 19.6, 17.6) groups.
The 1H NMR spectrum (Table 1, Supplementary Information, Figure S1) exhibited a doublet of an
olefinic proton at δH 6.66 (J = 0.8 Hz), a singlet of one proton at δH 3.20, two singlets of the tertiary
methyls at δH 1.50 and 0.89, in addition to the proton signals of the (3E)-5,6-dimethylhept-3-en-2-yl side
chain [δH 0.82, d, J = 6.8 Hz (H3-27), δH 0.84, d, J = 6.8 Hz (H3-28), δH 1.04, d, J = 6.8 Hz (H3-21), δH 5.15,
dd, J = 15.3, 7.3 Hz (H-22) and δH 5.25, dd, J = 15.3, 8.0 Hz (H-23)]. As both H3-21 and the methyl singlet
at δH 0.89 showed HMBC cross peaks to C-17 (δC 56.0), the methyl singlet at δH 0.89 was assigned to
CH3-18. Therefore, another methyl singlet (δH 1.50, δC 21.8) was assigned to CH3-19. Since the HMBC
spectrum (Table 1 and Figure 2, Supplementary Information, Figure S5) also exhibited cross peaks
from both H3-19 and the doublet of the olefinic proton at δH 6.66 (J = 0.8 Hz, H-4) to the quaternary sp2
carbon at δC 155.0, the double bond was placed between C-4 (δC 129.2) and C-5 (δC 155.5). Moreover,
H3-19 also showed HMBC cross peaks to the carbon signals at δC 43.9, 37.1 and 36.8, therefore, they
were assigned to C-9, C-1 and C-10, respectively. On the other hand, the carbons at δC 44.3 and 51.8
were assigned to C-13 and C-14 since they both showed HMBC cross peaks to H3-18. Moreover, since
the HMBC spectrum (Table 1 and Figure 2, Supplementary Information, Figure S5) also exhibited
cross peaks from the singlet at δH 3.20 to C-5, C-14, the carbons at δC 66.2 and δC 195.9, the carbon at
δC 66.2 was assigned to C-8 and one of the conjugated carbonyl (δC 195.9) was placed on C-6. This was
supported by the HMBC cross peak from H-4 to C-6. Therefore, another conjugated carbonyl group
(δC 199.5) must be on C-3. The fact that there was one more oxygen atom to be accounted for, along
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with the presence of the oxyquaternary carbon (δC 66.2), the epoxide function was placed between C-7
and C-8. Therefore, the structure of 1 was elucidated as 7,8-epoxyergosta-4,22-dien-3,6-dione.
Table 1. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 1.
Position δC, Type δH, (J in Hz) COSY ROESY HMBC
1α 37.1, CH2 1.81, m
β 2.18, m
2α 33.8, CH2 2.50,m H-1
β 2.64, dd (17.9, 7.2) H-1
3 199.5, CO -
4 129.2, CH 6.66, d (0.8) - C-2, 3, 5
5 155.0, C -
6 195.9, CO -
7 56.1, CH 3.20, s - H-9, 14, 15 C-5, 6, 8, 14
8 66.2, C -
9 43.9, CH 1.90, m
10 36.8, C -
11 20.7, CH2 1.85, m
12 39.0, CH2 1.21, m; 1.40, m
13 44.3, C -
14 51.8, CH 1.94, m
15 18.7, CH2 1.25, m
16 27.7, CH2 1.34, m; 1.75, m
17 56.0, CH 1.30, m
18 12.4, CH3 0.89, s C-12, 13, 14, 17
19 21.8, CH3 1.50, s - 1β, 2β C-1, 5, 9
20 40.0, CH 2.04, m
21 21.0 CH3 1.04, d (6.8) H-20 C-17, 20, 22
22 135.0, CH 5.15, dd (15.3, 7.3) H-20, 23 C-21, 24
23 132.5, CH 5.25, dd (15.3, 8.0) H-22, 24 C-20, 24, 25, 26
24 42.8, CH 1.85, m C-22, 23
25 33.0, CH 1.48, m
26 17.6, CH3 0.92, d (6.8) H-24 C-23, 24, 25
27 20.0, CH3 0.82, d (6.8) H-25 C-24, 25, 28
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has never been previously reported. Therefore, it is a new compound and was named talarosterone.
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The 1H, 13C NMR, IR and HRMS data of 2 (Supplementary information, Table S1, Figures S8–S12)
are compatible with those reported for cyathiserone [6]. The structure and the stereochemistry of 2
were confirmed by X-ray analysis and the ORTEP view is shown in Figure 5.
r
Figure 5. ORTEP diagram of compound 2.
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Compound 3 was isolated as a reddish orange solid (mp, 258–260 ◦C). The IR spectrum showed
absorption bands for hydroxyl (3463 cm−1), conjugated ketone carbonyl (1622 cm−1) and aromatic
(1550 cm−1) groups. The 13C NMR spectrum (Table 2, Supplementary Information, Figure S14)
exhibited fifteen carbon signals which, in conjunction with DEPTS and HSQC spectra (Supplementary
Information, Figure S16), can be categorized as two conjugated ketone carbonyls (δC 189.6 and 182.1),
nine quaternary sp2 (δC 164.4, 164.3, 161.1, 148.2, 133.2, 131.3, 123.5, 113.1, 108.9), three methine sp2
(δC 123.6, 120.5, 107.2) and one tertiary methyl (δC 21.5) groups. The 1H NMR spectrum (Table 2,
Supplementary Information, Figure S13) showed one singlet at δH 6.73 and two double doublets at
δH 7.15 (J = 1.0, 0.5 Hz) and 7.28 (J = 1.0, 0.5 Hz) of the aromatic protons and one singlet of the tertiary
methyl (δH 2.33), in addition to two singlets of the hydrogen-bonded hydroxyl groups at δH 12.04 and
δH 12.79.
Table 2. 1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment for 3.
Position δC, Type δH, (J in Hz) COSY HMBC
1 (1′) 164.3, C -
2 (2′) 123.5, C -
3 (3′) 107.2, CH 6.73, s - C-1 (1′), 4 (4′), 2 (2′), 4a (4′a)
4 (4′) 108.9, C -
4a (4′a) 108.9, C -
5 (5′) 161.1, C -
6 (6′) 123.6, CH 7.15, dd (1.0, 0.5) H-8 (8′), Me-7 (7′) C-5 (5′), 7 (7′), 8 (8′), 10a (10′a)
7 (7′) 148.2, C -
8 (8′) 120.5, CH 7.28, dd (1.0, 0.5) H-6 (6′), Me-7 (7′) C-6 (6′), 7 (7′), 9 (9′), 10a (10′a)
8a (8′a) 131.3, C * -
9 (9′) 182.1, CO -
9a (9′a) 133.2, C * -
10 (10′) 189.6, CO -
10a (10′a) 113.1, C -
CH3-7 (7′) 21.5, CH3 2.33, s H-6 (6′), 8 (8′) C-6 (6′), 7 (7′), 8 (8′)
OH-4 (4′) - 12.79, s - C-3 (3′), 4 (4′), 4a (4′a)
OH-5 (5′) - 12.04, s - C-5 (5′), 6 (6′), 10a (10′a)
* can be interchanged.
The 1H and 13C NMR features suggested that 3 was a polyhydroxy methyl anthraquinone.
That one of the benzene rings of 3 was a 3-hydroxy-5-methyl-1,2,3,5-tetrasubstituted was supported by
the COSY correlations (Table 2 and Figure 6, Supplementary Information, Figure S15) of the aromatic
protons at δH 7.15 (J = 1.0, 0.5 Hz, H-6) and 7.28 (J = 1.0, 0.5 Hz, H-8) with the methyl protons
at δH 2.33 as well as by the HMBC correlations from H-6 to C-8 (δC 120.5), C-5 (δC 161.1), C-10a
(δC 113.1), and CH3-7 (δC 21.5), from H-8 to C-6 (δC 123.6), C-10a and CH3-7 as well as from OH-5
(δH 12.04, s) to C-5, C-6 and C-10a (Table 2 and Figure 6, Supplementary Information, Figure S17).
Since the methyl protons showed HMBC correlation with the carbon at δC 148.2, it was assigned
to C-7. On the other hand, another benzene ring of 3 was 3, 6-dihydroxy-1,2,3,5,6-substituted
since the HMBC spectrum (Table 2 and Figure 6, Supplementary Information, Figure S17) exhibited
correlations from the aromatic proton singlet at δH 6.73 (H-3) to C-1 (δC 164.3), C-4 (δC 164.4), C-4a
(δC 108.9) as well as from the hydroxyl singlet at δH 12.79 (OH-4) to C-3 (δC 107.2), C-4 (δC 164.4) and
C-4a (δC 108.9). Moreover, the HMBC spectrum (Table 2 and Figure 6, Supplementary Information,
Figure S17) also exhibited a cross peak from H-8 to the carbonyl carbon at δC 182.1, the latter was
assigned to C-9. Since, there was no cross peak from H-3 to either of the carbonyl carbons, the
carbonyl carbon at δC 189.6 was assigned to C-10. The higher chemical shift value of C-10 than
that of C-9 was justified by its hydrogen bonding with both OH-4 and OH-5. By comparing the
13C NMR data of 3 to those of other anthraquinones isolated from this fungus, i.e., emodin (4a),
citreorosein (4c), fallacinol (4d) and rheoemodin (4e), the carbons at δC 131.3 and δC 133.2 were
assigned to C-8a and C-9a, respectively. Therefore, the structure of 3 was tentatively established as
7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. However, this structure (C15H9O5) was not complete
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since there was no substituent on C-2 (δC 123.5) to be accounted for. Since the (+)-HRESIMS of 3
gave the [M + H]+ peak at m/z 539.0942 [M + H]+, corresponding to C30H19O10 (calculated 539.0978),
the molecular formula of 3 was C30H18O10 (twenty-two degrees of unsaturation). Therefore, the
structure of 3 was a dimer of 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. This structure was also
supported by the HMBC correlation from H-2 to the quaternary sp2 carbon at δC 123.5 (C-2′). Therefore,
the structure of 3 was established as 2, 2′-bis-(7-methyl-1,4,5-trihydroxy-anthracene-9,10-dione).
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Position  δC, Type  δH, (J in Hz) COSY ROESY  HMBC
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5  155.0, C  ‐       
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19  21.8, CH3  1.50, s  ‐  1β, 2β  C‐1, 5, 9 
20  40.0, CH  2.04, m       
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26  17.6, CH3  0.92, d (6.8)  H‐24    C‐23, 24, 25 
27  20.0, CH3  0.82, d (6.8)  H‐25    C‐24, 25, 28 
28  19.6 CH3  0.84, d (6.8)  H‐25    C‐24, 25, 27 
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Literature search revealed that Tan et al. [20] have reported isolation of the structurally similar
bis-anthraquinone, named 2240A, from an unidentified endophytic fungus (strain no 2240), isolated
from the estuarine mangrove from the South China Sea Coast. The structure of 2240A is also a dimer of
7-methyl-1,4,5-trihydroxy-9,10-anthraquinone; however, the two anthraquinone monomers are linked
between C-3 and C-3′ instead of C-2 and C-2′ as in 3. Surprisingly, the 1H and 13C NMR chemical shift
values reported for 2240A by Tan et al. [20] were very similar to those of 3. Although the structures of
3 and 2240A cannot be distinguished by HMBC correlations, careful analysis of the 1H and 13C NMR
data of compound 2240A revealed that Tan et al. [20] assigned the chemical shift values to some of the
carbons differently from what we assigned for 3. Tan et al. [20] assigned the carbon signal at δC 108.7
to C-9a/9a′ (i.e., C-14/14′ for the numbering used by Tan et al.) instead of C-4a/4′a (i.e., C-13/13′ for
the numbering used by Tan et al.) and the carbon signal at δC 131.8 to C-4a/4′a (i.e., C-13/C-13′ for
the numbering used by Tan et al.) instead of C-9a/9a′ (i.e., C-13/C-13′ for the numbering used by
Tan et al.). This assignment seems to be incorrect since the chemical shift values of C-4a and C-10a
of a series of anthraquinones with the hydroxyl groups on C-4 and C-5 isolated from this extract, i.e.,
emodin (4a), citreorosein (4c), fallacinol (4d) and rheoemodin (4e), are ca. 108 and 115 ppm, which is far
from 133 ppm proposed by Tan et al. [19]. Consequently, we are convinced that the structure proposed
for compound 2240A is not correct. Interestingly, Tan et al. [19] reported 2240A as dextrorotatory,
displaying [α]20D +62.50 (c 0.08, dioxin). On the contrary, 3 is levorotatory having [α]
20
D −40 (c 0.05,
dioxin) and −100 (c 0.05, MeOH), respectively. Since 3 can be considered as a bridged biphenyl, it
can have a phenomenon of atropisomerism due to a restricted rotation of the phenyl rings around the
C-2/C-2′ bond. Therefore, 3 and compound 2240A, previously reported by Tan et al. [19] are different
and could probably be atropisomers.
The structure of 3 can be viewed as a dimer of helminthosporin, an anthraquinone previously
isolated from the subterranean stems of Aloe saponaria Haw. [21], and also from the roots of
Berchemia floribunda [22].
The structures of the other known compounds, i.e., palmitic acid, ergosta-4,6,8(14),22-tetraen-3-
one, ergosterol-5,8-endoperoxide, emodin (4a), questinol (4b), citreorosein (4c), fallacinol (4d),
rheoemodin (4e) and secalonic acid A (5) were elucidated by analysis of their 1H, 13C NMR and
HRMS spectra, and a rotation when the compounds have stereogenic carbons as well as by comparison
of these spectroscopic data with those reported in the literature.
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Emodin (4a), questinol (4b), citreorosein (4c), fallacinol (4d), rheoemodin (4e), and secalonic acid
A (5) were tested for their anti-obesity activity using the zebrafish Nile red assay. The results showed
that only the anthraquinones questinol (4b) and citreorosein (4c) had significant anti-obesity activity.
Questinol (4b) and citreorosein (4c) reduced >60% and >90% of the stained lipids with the IC50 values
of 0.95 and 0.17 µM, respectively. The positive control resveratrol (REV) had an IC50 value of 0.6 µM
(Figure 7). Interestingly, emodin (4a) and secalonic acid A (5) caused toxicity (death) for all exposed
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It is interesting to observe that questinol (4b), citreorosein (4c) and fallacinol (4d) are structurally 









Figure 7. Anti-obesity activity of compounds 4a–e and 5 in the zebrafish larvae Nile red assay.
The solvent control had 0.1% DMSO and the positive control received 50 µM resveratrol (REV).
Values are presented as mean fluorescence intensity (MFI) relative to the DMSO group, and are derived
from 10 to 12 individual larvae per treatment group. Statistical differences to the solvent control are
indicated with asterisks, *** = p < 0.001.
It is interesting to observe that questinol (4b), citreorosein (4c) and fallacinol (4d) are structurally
similar, all having a hydroxymethyl group on C-6 and a hydroxyl group on C-8. Replacing the hydroxyl
group on C-1 by a methoxyl group, as in questinol (4b), diminishes the activity whereas replacing
the hydroxyl group on C-3 with a methoxyl group, as in fallacinol (4d), completely removes the
anti-obesity activity. Therefore, it seems that the hydroxymethyl group on C-6 and the hydroxyl groups
on C-3 and C-8 are necessary for the anti-obesity activity of the polyhydroxy anthraquinones.
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Figure 8. Representative images of the zebrafish Nile red assay. The upper images show the overlay
of the fluorescence and phase contrast; the lower images show the mean fluorescence intensity (MFI)
given as black and white picture. DMSO, solvent control 0.1%.
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3. Experimental Section
3.1. General Experimental Procedures
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations
were measured on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent, UK).
Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from Thermo
Scientific (Waltham, MA, USA) with Smart OMNI-Transmission accessory (Software 188 OMNIC. 1H
and 13C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument (Bruker
Biosciences Corporation, Billerica, MA, USA) operating at 300.13 and 75.4 Hz or at 500.13 and
125.4 MHz, respectively. High resolution mass spectra were measured with a Waters Xevo QToF
mass spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC
system. A Merck (Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck
Si gel 60 (0.2–0.5 mm) was used for column chromatography.
3.2. Fungal Material
The strain KUFA 0207 was isolated from the marine sponge Stylissa flabelliformis, which was
collected by scuba diving at a depth of 10–15 m, from the coral reef at Samaesarn Island (12◦34′36.64′ ′ N
100◦56′59.69′ ′ E) in the Gulf of Thailand, Chonburi Province, in April 2014. The sponge was washed
with 1% sodium hypochlorite solution for 1 min, followed by sterilized seawater three times, and then
dried on sterile filter paper under a laminar flow hood, cut into small pieces (5 × 5 mm), and placed
on malt extract agar (MEA) plates containing 70% seawater and 300 mg/L of streptomycin sulfate.
The plates were incubated at 28 ◦C for seven days, after which the hyphal tips were transferred onto
a slant MEA and maintained as pure culture for further identification. The fungus was identified as
Talaromyces stipitatus C.R. Benj., based on morphological characteristics, and was also confirmed by
analysis sequence of the internal transcribed spacer (ITS) gene according to the procedure previously
described by us [23]. Its gene sequences were deposited in GenBank with accession number KU500028.
The pure cultures were deposited as KUFA 0207 at Kasetsart University Fungal Collection, Department
of Plant Pathology, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand. The fungus was
cultured for one week at 28 ◦C in 10 Petri dishes (i.d. 90 mm) containing 25 mL of MEA. In order
to obtain the mycelial suspension, the mycelial plugs were transferred to two 500 mL Erlenmeyer
flasks containing 200 mL of potato dextrose broth, and then incubated on a rotary shaker at 120 rpm
at 28 ◦C for one week. Fifty 1000 mL Erlenmeyer flasks, each containing 300 g of cooked rice, were
autoclaved at 121 ◦C for 15 min, and then inoculated with 20 mL of mycelial suspension of T. stipitatus
and incubated at 28 ◦C for 30 days, after which the moldy rice was macerated in ethyl acetate (25 L
total) for seven days, and then filtered. The ethyl acetate solution was concentrated under reduced
pressure to yield 65.6 g of crude ethyl acetate extract.
3.3. Extraction and Isolation
The crude ethyl acetate (35 g) was applied on a column of silica gel (335 g), and eluted with
mixtures of petrol-CHCl3 and CHCl3-Me2CO, 250 mL fractions were collected as follows: Frs 1–133
(petrol-CHCl3, 1:1), 134–249 (petrol-CHCl3, 3:7), 250–314 (petrol-CHCl3, 1:9), 315–440 (CHCl3-Me2CO,
9:1), 441–511 (CHCl3-Me2CO, 7:1), 512–546 (CHCl3-Me2CO, 1:1). Frs 156–170 were combined (382.7 mg)
and crystallized in methanol to give palmitic acid (20 mg). Frs 171–182 were combined (370 mg) and
purified by TLC (silica gel G254, CHCl3-petrol-EtOAc-HCO2H, 16:3:1:0.01) to give 1 (10.5 mg), palmitic
acid (21.7 mg) and ergosta-4,6,8(14),22-tetraen-3-one (23.3 mg). Frs 220–250 were combined (201.5 mg)
and crystallized in MeOH to give ergosta-4,6,8(14),22-tetraen-3-one (19.6 mg). Frs 315–317 were
combined (4.53 g) and applied over a column chromatography of silica gel (35 g) and eluted with
mixture of petrol-CHCl3 and CHCl3-Me2CO, wherein 250 mL fractions were collected as follows:
sfrs 1–101 (petrol-CHCl3, 1:1), 102-170 (petrol-CHCl3, 3:7), 171–296 (petrol-CHCl3, 1:9), 297–311
(CHCl3-Me2CO, 9:1). Sfrs 19–38 were combined (329 mg) and applied over a column chromatography
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of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of CHCl3:MeOH, to give forty 15 mL ssfrs. Ssfrs
8–37 were combined and purified by TLC (silica gel G254, CHCl3-petrol-EtOAc-HCO2H, 80:16.5:3.5:0.1)
to give 2 (12.2 mg). Sfrs 229–296 were combined (179 mg) and purified by TLC (silica gel G254,
CHCl3-petrol-EtOAc-HCO2H, 80:15:5:0.1) to give emodin (4a, 10 mg). Frs 318–330 were combined
(3.77 g) and applied over a column chromatography of silica gel (100 g) and eluted with a mixture
of petrol-CHCl3 and CHCl3-Me2CO, wherein 100 mL fractions were collected as follows: sfrs 1–118
(petrol-CHCl3, 1:1), 199–277 (petrol-CHCl3, 3:7), 278–289 (petrol-CHCl3, 1:9), 290–471 (CDCl3), 472–589
(CHCl3-Me2CO, 9:1), 590–633 (CHCl3-Me2CO, 7:3). Sfrs 238–395 were combined (473.7 mg) and
crystallized in a mixture of CHCl3 and petrol to give ergosterol-5,8-endoperoxide (22 mg). Sfrs 477
(146.2 mg) was crystallized in a mixture of CHCl3 and petrol to give a reddish orange solid of 3 (9 mg).
Sfrs 510–524 were combined (53 mg) and crystallized in CHCl3 to give yellow solid of fallacinol (4d,
21 mg). Frs 332–345 were combined (60.0 mg) and crystalized in a mixture of CHCl3 and MeOH to
give 15.2 mg of secalonic acid A. Frs 355–365 were combined (103.0 mg) and crystalized in a mixture
of CHCl3 and MeOH to an additional 10.5 mg of secalonic acid A, whereas the mother liquor was
further purified by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 4:1:0.01) to give 8.5 mg of citreorosein
(4c). Frs 392–440 were combined (316 mg) and crystallized in Me2CO to give questinol (4b, 10.7 mg).
Frs 443–450 were combined and crystallized in Me2CO to give rheoemodin (4e, 2.5 mg).
3.3.1. Talarosterone (1): (7R,8R)-Epoxyergosta-4,22-dien-3,6-dione
White crystal; mp 146–148 ◦C; [α]20D +204 (c 0.04, CHCl3); IR (KBr) υmax 2956, 2873, 1689, 1670,
1593, 1458, 1411, 1276, 1260 cm−1; For 1H and 13C spectroscopic data (CDCl3, 300.13 and 75.14 MHz),
see Table 1; (+)-HRESIMS m/z 425.3056 [M + H]+ (calcd. for C28H41O3, 425.3056).
3.3.2. Bis(1,4,5-Trihydroxy-7-methylanthraquinone) (3)
Reddish orange solid; mp 258–260 ◦C; [α]20D −100 (c 0.05, MeOH) and −40 (c 0.05, dioxin);
IR (KBr) υmax 3463, 2359, 1622, 1550, 1480, 1457, 1247, 1207 cm−1; For 1H and 13C spectroscopic
data (CDCl3, 500.13 and 75.4 MHz), see Table 2; (+)-HRESIMS m/z 539.0942 [M + H]+ (calcd. for
C30H19O10, 539.0978).
3.4. X-ray Crystal Structure of Compounds 1 and 20
Diffraction data were collected at 293 K with a Gemini PX Ultra equipped with CuKα radiation
(Oxford Diffraction, Abingdon, Oxfordshire, UK) (λ = 1.54184 Å). The structures were solved by direct
methods using SHELXS-97 and refined with SHELXL-97 [24]. Carbon and oxygen atoms were refined
anisotropically. Hydrogen atoms were either placed at their idealized positions using appropriate
HFIX instructions in SHELXL, and included in subsequent refinement cycles, or were directly found
from difference Fourier maps and were refined freely with isotropic displacement parameters. Full
details of the data collection and refinement and tables of atomic coordinates, bond lengths and angles,
and torsion angles have been deposited with the Cambridge Crystallographic Data Centre (CCDC).
Talarosterone (1). Crystals were orthorhombic, space group C2221, cell volume 5091.3(10) Å3 and
unit cell dimensions a = 8.4602(5) Å, b = 12.407(2) Å and c = 48.504(5) Å. The refinement converged to
R (all data) = 9.72% and wR2 (all data) = 15.83%. CCDC 1527335.
Cyathiserone (2). Crystals were monoclinic, space group P21, cell volume 1278.36(8) Å3
and unit cell dimensions a = 6.6142(2) Å, b = 6.46731(19) Å and c = 29.8941(13) Å and angle
β = 91.419(4)◦ (uncertainties in parentheses). The refinement converged to R (all data) = 6.96%
and wR2 (all data) = 14.86%. CCDC 1527349.
3.5. Anti-Obesity Assay
Compounds 4a–e and 5 were dissolved in DMSO at a concentration of 5 mM and stored at−20 ◦C
until analyses. Anti-obesity activity of the compounds was analyzed with the zebrafish Nile red assay
as described in Jones et al. [18] with some modifications. Zebrafish adults and larvae were maintained
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under standard conditions at 28 ◦C as defined in the zebrafish book available at the ZFIN database
(https://zfin.org/). In brief, zebrafish embryos were raised from 1 DPF (days post fertilization) in egg
water (60 µg/mL marine sea salt dissolved in distilled H2O) with 200 µM PTU (1-phenyl-2-thiourea)
to inhibit pigmentation. From 3 DPF to 5 DPF, zebrafish larvae were exposed to compounds at a
final concentration of 5 µM with daily renewal of water and compounds in a 24-well plate with a
density of 10–12 larvae/well. A solvent control (0.1% DMSO) and positive control (REV, resveratrol,
final concentration 50 µM) were included in the assay. Lipids were stained with Nile red overnight
at the final concentration of 10 ng/mL. For imaging, the larvae were anaesthetized with tricaine
(MS-222, 0.03%) for 5 min and fluorescence analyzed with a fluorescence microscope (Leica DM6000B,
Wetzlar, Germany). Fluorescence intensity was quantified in individual zebrafish larvae by ImageJ
(http://rsb.info.nih.gov/ij/index.html).
4. Conclusions
The ethyl acetate extract from the culture of the marine sponge-associated fungus
Talaromyces stipitatus KUFA 0207 furnished a new ergosterol derivative (1), a new bis-anthraquinone
derivative (3), and ten known compounds including palmitic acid, ergosta-4,6,8(14),22-tetraen-3-one,
ergosterol-5,8-endoperoxide, cyathisterone (2), and the previously reported anthraquinones emodin
(4a), questinol (4b), citreorosein (4c), fallacinol (4d), rheoemodin (4e), as well as secalonic acid A
(5). The stereochemistry of the stereogenic carbons of compounds 1 and 2 was established by X-ray
analysis. Compounds 4a–e and 5 were tested for their anti-obesity activity by the zebrafish Nile red
assay using resveratrol as a positive control. Citreorosein (4c) exhibited strong anti-obesity activity
(IC50 = 0.17 µM), while questinol (4b) showed moderate activity (IC50 = 0.95 µM) in this test system.
Analysis of the structures of the anthraquinones tested revealed that the hydroxymethyl group on C-6
and the hydroxyl groups on C-3 and C-8 are required for the anti-obesity activity. The results obtained
from this study suggested that marine-derived fungi of the genus Talaromyces can be a promising
source of compounds with potential anti-obesity activity.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/5/139/s1.
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